{
    "nct_id": "NCT03264456",
    "official_title": "Pretreatment Staging of High-Risk Prostate Cancer With 18F-Fluciclovine PET/MRI",
    "inclusion_criteria": "- High-risk biopsy-proven treatment-naïve prostate adenocarcinoma (Gleason score ≥ 8 and/or serum PSA > 20)\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Inability to tolerate or undergo PET/MRI\n* Previous or current hematologic or lymphatic disorder (including leukemia, lymphoma, Castleman's disease, etc.)\n* Recurrent prostate adenocarcinoma\n* Known visceral, osseous, or extrapelvic metastases prior to fluciclovine-PET/MRI\n* Known allergy to glucagon or gadolinium-based contrast",
    "miscellaneous_criteria": ""
}